Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02766998 · ClinicalTrials.gov registry record · NA
Preserved Umbilical Vein Use as Autologous Shunt Conduits in Neonatal Cardiac Surgery
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02766998 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 2 participants.
The verdict
NCT02766998, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a prospective, single center, safety and feasibility trial to evaluate the use of autologous umbilical vein as shunts or conduits in neonatal cardiac surgery. Subjects will be identified here at the Advanced Fetal Care Center (AFCC) following diagnosis of congenital heart disease (CHD) with single ventricle physiology of the fetus via fetal echocardiogram. At time of cesarean section or vaginal delivery, umbilical cord will be harvested in a sterile fashion and the umbilical vein will be dissected free and preserved until first clinically indicated Stage I palliative procedure between day 3 and 7 of life. Subjects will be followed until their Stage II palliative procedure.
Interventions
- PROCEDURE Preserved umbilical vein as shunt/conduit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-05-16 |
| Est. Completion | 2021-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02766998
The ClinicalTrials.gov registry entry for NCT02766998 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preserved umbilical vein as shunt/conduit is the first listed.
NCT02766998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02766998 about?
NCT02766998 is a clinical study titled "Preserved Umbilical Vein Use as Autologous Shunt Conduits in Neonatal Cardiac Surgery". This is a prospective, single center, safety and feasibility trial to evaluate the use of autologous umbilical vein as shunts or conduits in neonatal cardiac surgery. Subjects will be identified here at the Advanced Fetal Care Center (AFCC) following diagnosis of congenital heart disease (CHD) with ...
What is the current status of trial NCT02766998?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2016-05-16. Estimated completion is 2021-11-15.
What interventions are being tested in trial NCT02766998?
The interventions under investigation include: Preserved umbilical vein as shunt/conduit (PROCEDURE).
Who is sponsoring clinical trial NCT02766998?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.